These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 11774471

  • 1. Involvement in fusion activity of an epitope in the S2 subunit of murine coronavirus spike protein.
    Taguchi F, Shimazaki YK.
    Adv Exp Med Biol; 2001; 494():213-8. PubMed ID: 11774471
    [No Abstract] [Full Text] [Related]

  • 2. Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity.
    Taguchi F, Shimazaki YK.
    J Gen Virol; 2000 Dec; 81(Pt 12):2867-2871. PubMed ID: 11086117
    [Abstract] [Full Text] [Related]

  • 3. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y, Lu H, Siddiqui P, Zhou Y, Jiang S.
    J Immunol; 2005 Apr 15; 174(8):4908-15. PubMed ID: 15814718
    [Abstract] [Full Text] [Related]

  • 4. Effects of amino acid insertions in the cysteine-rich domain of the MHV-A59 spike protein on cell fusion.
    Chang KW, Gombold JL.
    Adv Exp Med Biol; 2001 Apr 15; 494():205-11. PubMed ID: 11774470
    [No Abstract] [Full Text] [Related]

  • 5. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.
    Kuo L, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ.
    J Virol; 2000 Feb 15; 74(3):1393-406. PubMed ID: 10627550
    [Abstract] [Full Text] [Related]

  • 6. Receptor specificity and receptor-induced conformational changes in mouse hepatitis virus spike glycoprotein.
    Holmes KV, Zelus BD, Schickli JH, Weiss SR.
    Adv Exp Med Biol; 2001 Feb 15; 494():173-81. PubMed ID: 11774465
    [No Abstract] [Full Text] [Related]

  • 7. In vitro properties and pathogenesis of A59/MHV4 chimeric mouse hepatitis viruses.
    Tsai JC, Weiss SR.
    Adv Exp Med Biol; 2001 Feb 15; 494():169-72. PubMed ID: 11774464
    [No Abstract] [Full Text] [Related]

  • 8. Single amino acid changes in the S2 subunit of the MHV surface glycoprotein confer resistance to neutralization by S1 subunit-specific monoclonal antibody.
    Grosse B, Siddell SG.
    Virology; 1994 Aug 01; 202(2):814-24. PubMed ID: 8030244
    [Abstract] [Full Text] [Related]

  • 9. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion.
    Krueger DK, Kelly SM, Lewicki DN, Ruffolo R, Gallagher TM.
    J Virol; 2001 Mar 01; 75(6):2792-802. PubMed ID: 11222703
    [Abstract] [Full Text] [Related]

  • 10. Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor.
    Matsuyama S, Taguchi F.
    Virology; 2002 Mar 30; 295(1):160-71. PubMed ID: 12033774
    [Abstract] [Full Text] [Related]

  • 11. The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity.
    Bos EC, Luytjes W, Spaan WJ.
    J Virol; 1997 Dec 30; 71(12):9427-33. PubMed ID: 9371603
    [Abstract] [Full Text] [Related]

  • 12. Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein.
    Navas-Martin S, Hingley ST, Weiss SR.
    J Virol; 2005 Jun 30; 79(12):7629-40. PubMed ID: 15919915
    [Abstract] [Full Text] [Related]

  • 13. N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.
    Miura HS, Nakagaki K, Taguchi F.
    J Virol; 2004 Jan 30; 78(1):216-23. PubMed ID: 14671103
    [Abstract] [Full Text] [Related]

  • 14. Coronavirus-induced membrane fusion requires the cysteine-rich domain in the spike protein.
    Chang KW, Sheng Y, Gombold JL.
    Virology; 2000 Mar 30; 269(1):212-24. PubMed ID: 10725213
    [Abstract] [Full Text] [Related]

  • 15. Receptor-induced conformational changes of murine coronavirus spike protein.
    Matsuyama S, Taguchi F.
    J Virol; 2002 Dec 30; 76(23):11819-26. PubMed ID: 12414924
    [Abstract] [Full Text] [Related]

  • 16. Mutation of the immunodominant CD8+ epitope in the MHV-4 spike protein.
    Chua MM, Phillips JJ, Seo SH, Lavi E, Weiss SR.
    Adv Exp Med Biol; 2001 Dec 30; 494():121-5. PubMed ID: 11774455
    [No Abstract] [Full Text] [Related]

  • 17. Inefficient infection of soluble receptor-resistant mutants of murine coronavirus in cells expressing MHVR2 receptor.
    Matsuyama S, Taguchi F.
    Adv Exp Med Biol; 2001 Dec 30; 494():233-6. PubMed ID: 11774474
    [No Abstract] [Full Text] [Related]

  • 18. A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.
    Yoo D, Deregt D.
    Clin Diagn Lab Immunol; 2001 Mar 30; 8(2):297-302. PubMed ID: 11238212
    [Abstract] [Full Text] [Related]

  • 19. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.
    Li F, Li W, Farzan M, Harrison SC.
    Science; 2005 Sep 16; 309(5742):1864-8. PubMed ID: 16166518
    [Abstract] [Full Text] [Related]

  • 20. Substitutions of conserved amino acids in the receptor-binding domain of the spike glycoprotein affect utilization of murine CEACAM1a by the murine coronavirus MHV-A59.
    Thackray LB, Turner BC, Holmes KV.
    Virology; 2005 Mar 30; 334(1):98-110. PubMed ID: 15749126
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.